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Abstract 
Background: Double coronary culprit lesions in ST-segment elevation myocardial in-
farction (STEMI) is uncommon. Despite successful primary percutaneous coronary 
intervention (PPCI) in all culprit lesions, the clinical outcome remains unfavorable and 
the possible factors for the outcome are not fully understood. 
Cases Presentation: We reported four cases of double culprit lesions STEMI under-
went PPCI. Patient A, a 62 y.o. male with extensive anterior-inferior STEMI, had total 
occlusion (TO) at both proximal left anterior descending (LAD) and mid right coro-
nary artery (RCA). Patient B, a 42 y.o. male with extensive anterior-inferior STEMI, 
had subtotal occlusion (STO) at proximal RCA and TO at proximal LAD. Both of 
them had RBBB ECG pattern. Patient C, a 67 y.o. male with inferior STEMI had 90% 
thrombus occlusion at proximal–mid LAD and TO at proximal RCA. Patient D, a 65 
y.o. male with anteroseptal STEMI, had STO at proximal LAD and 80% thrombus 
occlusion at mid left circumflex. The cardiomyocyte infarction biomarkers increased 
in all patients. Although all of them underwent successful PPCI in all of culprit lesions, 
they suffered from acute heart failure and two of them experienced recurrent ventric-
ular arrhythmia episodes. One of them (patient A) died two days post PPCI. He was 
only patient who suffering from total occlusion in LAD and RCA with TIMI thrombus 
5 and experienced a total atrioventricular block post-PPCI. 
Conclusion: STEMI with coronary double culprits have severe clinical outcome, re-
gardless of the successful PCI. The degree of coronary occlusions might be linked to 
the patient clinical outcome   
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INTRODUCTION 
 ST-segment elevation myocardial infarction 
(STEMI) is a cardiac event caused by rupture of coro-
nary plaque leading to activation of platelets, formation 
of thrombus and occlusion of the coronary culprit.1 Typ-
ical clinical presentation of patients is chest discomfort 
accompanied with diaphoresis, nausea or vomitus.1 Elec-
trocardiogram (ECG) criteria is pivotal in diagnosing of 
patient with STEMI. Management of this complicated 
condition is challenging and time-limited. Appropriate 
clinical approach and rapid revascularization strategy are 
important to reduce mortality and morbidity in STEMI 
patients.  
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Primary percutaneous intervention (PPCI) is the recom-
mended strategy of reperfusion in STEMI patient within 
12 hours of symptom onset.1,2 
  Incidence rate of STEMI due to a simultaneous dou-
ble culprit lesion of coronary arteries is rare with a range 
from 1.7 to 4.8 in all PPCI.1Less than 30 PPCI cases have 
been reported. It remains unclear how coronary arteries 
are occluded simultaneously. Several factors may be in-
volved in the event, including hypercoagulability, mul-
tivessel spasm, thrombocythemia, and cocaine abuse. 
Traditional risk factors of coronary artery disease such 
as diabetes mellitus (DM), cigarette use, and 
dyslipidemia also contribute to the occlusion.3,4 
 Clinical outcome of STEMI patients with double 
culprit lesions is expected to be worse than those with 
single culprit.  An acute thrombotic occlusion of more 
than one coronary tree causes an extensive myocardial 
infarction. The later links to worse clinical outcome in-
cluding a high risk of mortality.5 
 
1. CASEPRESENTATION 
 In this report, we presented 4 cases of patients suf-
fering from STEMI with double coronary culprit lesions 
underwent successful PPCI, however the outcomes re-
mained unfavorable. 
 Patient A, a 62 y.o. male with a 3-hour onset of acute 
crushing retrosternal chest pain with coronary artery dis-
ease (CAD) risk factor was an active smoker with 3 packs 
a day for years. On physical examination, his respiratory 
rate (RR) was 22 times per minute, heart rate (HR) was 
86 times per minute, and blood pressure (BP) was 140/91 
mmHg. Jugular veins, pulmonary sound, and cardiac 
physical examination were within normal limits. Periph-
eral pulses were intact with no oedema. His initial elec-
trocardiogram (ECG) showed ST-segment elevations in 
the inferior (II, III, and a VF) and anterior (V3–V6) leads 
with incomplete RBBB pattern (Figure 1a), indicated 
acute inferior and anterior STEMI. The patient received 
loading doses of dual antiplatelet (320 mg aspirin and 180 
mg ticagrelor) as well as 80 mg atorvastatin. Coronary 
angiography procedure revealed thrombus type total oc-
clusions (TO) at the mid right coronary artery (RCA) 
(Figure 1c) and proximal left artery descending (LAD) 
(Figure 1d). A drug eluting stent (DES) was implanted at 
proximal LAD (Figure 1e), and sequentially followed by 
RCA intervention using two DES at mid and distal part 
of RCA (Figure 1d). TIMI grade 3 flow was seen in both 
LAD and RCA, neither residual stenosis nor dissection 
was observed. The echocardiogram data showed a low 
left ventricular ejection fraction (LVEF) (Table 1) and 
the patient was managed with intravenous diuretic and 
nitrate. Two days post PPCI, during hospitalization in the 
intensive cardiac care unit, the patient was unconscious-





Figure 1. Electrocardiogram (ECG) and coronary angiogram of patient A. (a) Initial ECG pre-primary percutaneous in-
tervention (PPCI) showed ST-segment elevation in the inferior (II, III, and a VF) and anterior (V3–V6) leads with incom-
plete right bundle branch block (RBBB) pattern, (b) the ECG post PPCI, (c) and (d) the respective angiograms of right 
coronary artery (RCA) and left anterior descending artery (LAD) pre PPCI, (e) and (f) the respective angiograms of RCA 
and LAD post PPCI. Arrowheads in (a) and (b) indicate the abnormality of ECG and in (c) and (d) point to the occluded 
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ventricular tachycardia (VT) that unresponsive to both 
medical and electrical treatments. After 45 minutes car-
diopulmonary resuscitation, the patient passed away. His 
laboratory result showed increase level of CKMB 471 
unit/L and troponin I>40ug/L, with a slight hypokalemia 
3.4mmol/L (Table 1). Although the cause of deteriora-
tion remained unclear, the event of TAVB and increase 
of troponin level suggested that the patient experienced 
an acute coronary thrombosis again.  
 Patient B, a 42 y.o. male presented with a typical 
angina pectoris,4.5 hours onset, accompanied by diapho-
resis and nausea. His CAD risk factors were hyperten-
sion and active smoker with one pack cigarettes per day 
for the past 10 years. The physical examination showed 
RR 24 times per minute, HR 100 times per minute, and 
BP 114/91 mmHg. Cardiac and pulmonary physical ex-
amination were within normal limits. His ECG revealed 
elevation of ST-segment in the inferior (II, III, and a VF) 
and anterior (V3–V6) leads with incomplete RBBB pat-
tern (Figure 2a). Loading doses of aspirin 320 mg, ti-
cagrelor 180 mg, and 80 mg atorvastatin were adminis-
trated. PPCI was performed and coronary angiogram 
showed a thrombus type lesion at the proximal portion 
of RCA (Figure 2c) and totally occluded of proximal por-
tion of LAD (Figure 2d). Proximal LAD was implanted 
one DES (Figure 2f) and middle part RCA was implanted 
one DES (Figure 2e) with TIMI grade 3 flow and no re-
sidual stenosis. Post PPCI procedure, the patient got pul-
monary edema managed with nitrate and diuretic. The pa-
tient’s symptoms and the ECG (Figure 2b) were signifi-
cantly improved and there was no further orthopnea. Pa-
tient was transferred into cardiac intensive care unit and 
received dual antiplatelet aspirin and ticagrelor, ACE-in-
hibitor, and atorvastatin 40 mg once daily. Fondaparinux 
was given until the patient was discharged from hospital. 
 Patient C, a 67 y.o. male with CAD risk factors of 
active smoker two pack cigarettes per day for the last 8 
years and dyslipidemia. He came to emergency room 
with 3 hours onset of retrosternal chest pain, diaphoresis, 
and vomitus. The    physical    examination    showed    
RR was 18 times per minute, HR was 87 times per mi-
nute, and BP was 124/95 mmHg. Cardiopulmonary phys-
ical examination was normal. His initial ECG showed 
ST-segment elevation in the inferior (II, III, and a VF) 





Figure 2. ECG and coronary angiogram of patient B. (a) Initial ECG pre-PPCI showed ST-segment elevation in the inferior (II, 
III, and a VF) and anterior (V3–V6) leads with incomplete RBBB pattern, (b) the ECG post PPCI, (c)–(e) the respective angio-
grams of RCA and LAD: (c) and (d) pre-PPCI, (e) and (f) post PPCI. Please see Figure 1 for the abbreviations and annotation 
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inferior and anterior STEMI. Aspirin 320mg, ticagre-
lor180mg, and atorvastatin 80mg were given before 
PPCI. Coronary angiogram revealed a thrombus type to-
tal occlusion in proximal RCA(Figure3c) and 90% ste-
nosis in proximal LAD with a hazy filling defect (Fig-
ure3d). During PPCI, the patient developed several epi-
sodes of ventricular fibrillation. PPCI was performed, 
each of the RCA (Figure3e) and LAD (Figure 3f) was 
stented with one DES. In the final angiogram, TIMI 
grade flow in LAD was 3, but in the RCA was 2.  Echo-
cardiographic examination was performed and the LVEF 
was low (Table 1) and thus an intravenous diuretic and 
nitrate were given. He was discharged on day 5th with 
aspirin 80 mg once daily, ticagrelor 90 mg twice a day 
as well as ACE-inhibitor, beta blocker and atorvastatin 
40 mg once daily. 
 Patient D, a 65 y.o. male with history of type II dia-
betes mellitus, hypertension, and dyslipidemia came 
with 24 hours onset of typical angina pectoris, diaphore-
sis, and nausea. Physical examination showed RR 22 
times per minute, HR 78 times per minute, and blood 
pressure was 98/87 mmHg. No abnormality was found 
in the cardiopulmonary physical examination. Peripheral 
pulses were intact with no oedema. His initial ECG 
showed ST segment elevation in anterior (V1-V4) leads 
(Figure 4a). The patient was loaded with aspirin 320 mg, 
ticagrelor 180 mg, and atorvastatin 80 mg and immedi-
ately sent to catheterization laboratory for PPCI. Coro-
nary angiography procedure showed a thrombus type 
subtotal occlusion in proximal LAD (Figure 4c) and in 
mid left circumflex (LCx) artery (Figure 4d). The patient 
underwent successful PPCI, TIMI grade 3 flow, with one 
DES was implanted in each of LAD and LCx (Figure 4e 
and f). Although the patient experienced pulmonary 
edema, his symptoms and the ECG (Figure 4b) were sig-
nificantly improved and patient transferred to intensive 
care unit. His LVEF was 48%. Then, he was regularly 
managed with dual antiplatelets aspirin and ticagrelor, 
atorvastatin, and ACE-inhibitor. Fondaparinux was given 
for 5 days. The patient was discharge after 7 days hospi-
talization. 
 Follow up data during hospitalization showed that all 
patients had acute heart failure (Table 1) as the compli-
cation of acute STEMI regardless of successful coronary 







Figure 3. ECG and coronary angiogram of patient C. (a) Initial ECG pre-PPCI showed ST-segment elevation in the inferior (II, 
III, and a VF) and anterior (V4–V6) leads, (b) the ECG post PPCI, (c)–(e) the respective angiograms of RCA and LAD: (c) and 
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2. DISCUSSION 
 STEMI is resulted from erosion or rupture of ather-
omatous plaque followed by thrombotic occlusion of 
coronary artery.1,2 In the daily clinical practice, spontaneous 
occlusion of two coronary arteries is rare, with the esti-
mated prevalence around 2.5%.6 But the actual number 
of the prevalence could be underestimated because of 
bias of selection associated with fatal outcomes.2 In 
STEMI patients with culprits in two vessels, the most 
frequent finding in coronary angiogram is occlusions of 
two arteries originating from different sides of a coro-
nary tree.2,7 In a case series of 18 patients, nine patients 
showed double occlusion in both RCA and LCx,6 how-
ever after adding 29 cases, most of the double occlusion 
was in the RCA and LAD.1,2,7 In our current case series, 
3 patients presented concomitant thrombosis in LAD and 
RCA, while one patient in LAD and LCx. A simultane-
ous occlusion of LAD and LCx in patients with STEMI 
is very rare.8 
 The underlying mechanism responsible for multiple 
vessel culprits remains unclear. A proposed mechanism 
is linked to inflammatory response inducing diffuse de-
stabilization of plaques in more than coronary vessels.4,7 
Since acute coronary syndrome is an exacerbation of 
chronic inflammatory disease in atherosclerosis, the term 
“pancoronaritis” is then established. A study reported 
that more than thirty percent of patients with acute coronary 
syndrome had multiple plaque ruptures with overlying 
thrombi.4 This was supported by another report from an 
autopsy of STEMI patients which found multiple throm-
boses in the coronarytree.9The multiple plaque ruptures 
can be not only came from simultaneous, but also sequen-
tial thrombotic occlusion of more than one coronary ar-
teries.11,12Further possible mechanism is that the occlu-
sion of a coronary artery may induce hemodynamic in-
stability and hypotension resulting in stasis of blood in-







Figure 4. ECG and coronary angiogram of patient D. (a) Initial ECG pre-PPCI showed ST-segment elevation in the anterior 
(V1–V4) leads, (b) the ECG post PPCI, (c)–(e) the respective angiograms of LAD and left circumflex artery (LCx): (c) and (d) 
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 In the current case series, all patients had acute heart 
failure following myocardial infarction and two of them, 
patients A and C, experienced a malignant arrhythmia. 
In addition to ventricular arrythmia, patient A suffered 
from total AV block and thus had an unfavorable out-
come ended with a mortality. The possible risk factors 
for having these catastrophic complications were hyper-
tension, history of smoking, poorly controlled lipid pro-
file and diabetes mellitus. Other possible mechanisms 
that may involve in clinical outcome severity are hyper-
coagulable state and autoimmune diseases including in-
Table 1. Clinical, laboratory, electrocardiographic, and angiographic characteristics of patients 
 Patient A  Patient B  Patient C  Patient D  Normal 
Value 
Clinical data      
Age (years old) 62 42 67 65  
Sex Male Male Male Male  
Onset of angina (hours) 3 4.5 3 12  
























      
Laboratory data      
CKMB (U/L) 471 88 378 21 7-25 
Troponin I (ug/L) 0.449 >50 0.014 >40 0.015-0.038 
Haemoglobin (g/dL) 14.8 16.6 13.5 11 13-16 
Leucocyte (103/uL) 15 20.9 10.8 11.1 3.8-10.6 
Thrombocyte (103/uL) 301 335 380 243 150-400 
Ureum (mg/dL) 35 24 28 73 15-39 
Creatinine (mg/dL) 1.14 0.7 0.89 1.12 0.6-1.3 
Magnesium (mmol/L) 0.92 0.8 0.78 1.0 0.74-0.99 
Calcium (mmol/L) 2.04 2.2 2.37 1.93 2.12-2.52 
Sodium (mmol/L) 145 139 132 127 136-145 
Potassium (mmol/L) 3.4 4.8 3.8 3.5 3.5-5.1 
Chloride (mmol/L) 103 106 98 96 98-107 
Blood glucose (mg/dL) 154 244 316 111 80-160 
Fasting glucose (mg/dL) 133 158 189 127 <125 
Total cholesterol (mg/dL) 170 209 160 199 <200 
Triglyceride (mg/dL) 150 173 75 227 <150 
HDL cholesterol (mg/dL) 31 32 47 19 40-60 
LDL cholesterol (mg/dL) 127 157 96 140 0-100 
HbA1C (%) 5.2 6.6 10.4 8.8 6-8 
 
Coronary intervention data 
     





























TIMI frame count post 
stenting 
      
RCA 13 frames 19 frames 29 frames 18 frames  
      
LCx 5 frames 11 frames 8 frames 10 frames  
LAD (corrected) 22.36 frames 11.18 frames 17.65 frames 7.06 frames  






QS at anterior 
leads 
QS at inferior 
leads 
QS at anteroseptal 
leads 
 
       
Echocardiogram        
LVEF (%) 35 42 36 48 >50 
       
Clinical outcome AHF, TAVB, 
ventricular ar-
rhythmia  
AHF AHF, ventricular 
arrhythmia 
AHF   
RBBB, right bundle branch block; PPCI, primary percutaneous intervention, TO, total occlusion; STO, sub-total occlusion; 
pLAD, proximal left anterior descending artery; mRCA mid right coronary artery; mLCx, mid left circumflex artery; TAVB, 
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creased frequency of factor V Leiden, prothrombin vari-
ant 20210A, and elevated levels of lipoprotein(a).7In pa-
tients A and C, these factors may be considered to be 
checked. 
 Numerous factors could affect the clinical status, in-
cluding degree of coronary occlusions, vascular tonus, 
diameter of vessel, and adrenergic surge.8 The degree of 
coronary occlusions refers to the angiographic thrombus 
burden classification published elsewhere.9 The exist-
ence of new right bundle branch block in patient with 
anterior STEMI and a high level of biomarker of cardiac 
myocyte infarction (Figure 1 and 3 and Table 1) indi-
cates a wide area of myocardial infarction and link to 
poor prognosis as well as high mortality. Thrombus type 
total occlusion of two major coronary arteries was con-
sidered as the cause of mortality of patient A in this se-
ries, as can be seen in Figure 1 to 4 and Table 1 that only 
patient A had thrombus type total occlusion in two cor-
onary arteries. Furthermore, TIMI frame count of LAD 
post stenting was higher in the patient A and C (Table 1) 
suggesting that there was a microcirculation impairment 
of the myocardium in those patients. The deteriorated 
condition in patient A may related with the impairment. 
This is supported by a report by Gibson et al. that in-
creasing of TIMI frame count is related with worst clin-
ical outcome.10 Thus, taken together, the degree of coro-
nary occlusions might be linked to the clinical outcome 
of the patients.   
 All coronary culprit lesions of patients in these cases 
were revascularized during PPCI. The number of re-
ported cases with simultaneous thrombotic occlusions of 
multiple coronary arteries remained small and thus the 
management and outcome of patients with this charac-
teristic are still not fully discussed in the recent STEMI 
guidelines. Recent studies find a benefit of complete re-
vascularization in patients with STEMI,13,15 and thus 
support the idea of complete revascularization during 
acute phase of patient with two culprit `arteries.1,2,4 
 Anticoagulant prescription post primary PCI re-
mains controversial.1,16 However, in all patients in this 
series received anticoagulant therapy after revasculariza-
tion to prevent further thrombosis. Benefit of anticoagu-
lant therapy in a high thrombus burden patient should be 
considered carefully while the risk of bleeding must be 
calculated as well. Therefore, a routine anticoagulation 
post PPCI should be avoided unless an indication is pre-
sent and should consider benefit-risk profile.16 Although 
all patients in this case series did not treated with a gly-
coprotein IIb/IIIa inhibitor, the use of this intravenous 
antiplatelet during PPCI should be considered if there is 
evidence of no-reflow or a thrombotic complica-
tion.1Therefore, in the case high thrombus burden with 
high risk of recurrent thrombosis, intravenous anticoag-
ulant or antiplatelet should be given post PPCI during 
hospitalization with causation of bleeding risk.  
 
3. CONCLUSION 
In the conclusion, we reported 4 cases of patients suffer-
ing from STEMI with double coronary culprit lesions 
underwent successful percutaneous coronary interven-
tion, however the clinical outcome remained unfavora-
ble. The degree of coronary occlusions might be linked 
to the patient clinical outcome. 
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